Estimation of Russian medical universities performance based on multidimensional analysis methods
Abstract
The monitoring of educationaL institutions performance on various indicators groups is annuaLLy carried out by the Ministry of Education and Science of the Russian Federation. Target indicators, determined for each group act as integraL quaLity quantitative criteria of
Interferon discovery and its clinical experience
Abstract
This review focuses on the discovery history of interferon and its therapeutic use. Interferons were first described 60 years ago as potent antiviraL agents reLated to the body's first Line of defense. This paper presents the domestic and internationaL experience with the
Prevention of influenza and acute viral infections in pregnant women and newborns
Abstract
The article presents our own study results and data from domestic and foreign literature review on the influenza and other acute respiratory viral infections in pregnant women and newborns. The impact of respiratory viral infections on pregnancy and the fetus is also
New perspectives in the treatment of allergic rhinitis and conjunctivitis: topical medications
Abstract
This paper presents a literature review on the topical treatment of persistent allergic rhinitis and allergic conjunctivitis. The clinical efficacy and safety data of a new combined medication Allergoferon® for topical application are provided. Taking these results into
Prospects for the topical therapy in patients with relapsing herpes infection
Abstract
Herpes virus infections cause imbaLance in the interferon system as weLL as suppress ceLLuLar and phagocytic reactions in vivo. Here, we demonstrate the high efficacy of Herpferon® ointment in the treatment and prevention of herpes simpLex and herpes zoster.
Experience of the combined medication Vagiferon® in non-pregnant women
Abstract
Protection against ascending genitaL tract infection can onLy be guaranteed with the use of combination therapy aimed at reducing the number of bacteriaL pathogens in the vagina and improving generaL and LocaL immune resistance. The addition of interferons to the combination
Efficacy of the medication Grippferon® for the prevention and treatment of acute respiratory viral infections in children with tuberculosis
Abstract
This paper presents the study results of the medication Grippferon® for the prevention and treatment of ARVI in children with tuberculosis. Our results demonstrate satisfactory tolerability and efficacy of this medication: among children, who received Grippferon, 92.9%
Treatment optimization in women with recurrent vaginitis and nonspecific cervicitis
Abstract
This paper presents the treatment results of nonspecific vaginitis - one of the current problems in gynecological practice. Objective - to improve the treatment efficacy of relapsing nonspecific vaginitis and cervicitis in women of reproductive age. Material and
Experience with the medication Grippferon® with loratadine for the treatment and prevention of ARVI in patients with allergic rhinitis
Abstract
Objective - to determine the perspectives of the new combined medication Grippferon® with Loratadine for the prevention and treatment of infLuenza and acute respiratory viraL infections (ARVI) in patients with aLLergic rhinitis during the epidemic rise of infLuenza and
Ophtalmoferon® - 15 years of widespread use in the treatment and prevention of infectious eye diseases
Abstract
This review summarizes the widespread experience with the interferon-based medication Ophtalmoferon® in the form of stable eye drops for the treatment and prevention of inflammatory eye diseases. Due to the complex composition, this medication has a pronounced
The significance of comorbidity in HIV infection
Abstract
Antiretroviral therapy (ART) in the proportion of patients with HIV infection does not lead to increase in CD4+ cell count during treatment. Currently, the HIV epidemic is largely represented by comorbid and severe forms of the disease. In the observational cohort